In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 2.9%. Helping drag down the group were shares of Avino Silver & Gold Mines, off about 8% and shares of Perpetua Resources down about 7.7% on the day. Also lagging the market Wednesday are biotechnology shares, down on the day by about 2.6% as a group, led down by Allogene Therapeutics, trading lower by...
In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 2.9%. Helping drag down the group were shares of Avino Silver & Gold Mines, off about 8% and shares of Perpetua Resources down about 7.7% on the day. Also lagging the market Wednesday are biotechnology shares, down on the day by about 2.6% as a group, led down by Allogene Therapeutics, trading lower by about 22.1% and Xilio Therapeutics, trading lower by about 15.6%. VIDEO: Wednesday Sector Laggards: Precious Metals, Biotechnology Stocks The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Wednesday, shipping shares were relative leaders, up on the day by about 2.3%. Leading the group were shares of CMB.TECH, up about 5.5% and shares of Genco Shipping & Trading up about 5% on the day. Also showing relative strength are agriculture & farm products shares, up on the day by about 1.7% as a group, led by Adecoagro, trading higher by about 10.1% and Cresud, trading up by ab...
In trading on Wednesday, shipping shares were relative leaders, up on the day by about 2.3%. Leading the group were shares of CMB.TECH, up about 5.5% and shares of Genco Shipping & Trading up about 5% on the day. Also showing relative strength are agriculture & farm products shares, up on the day by about 1.7% as a group, led by Adecoagro, trading higher by about 10.1% and Cresud, trading up by about 0.3% on Wednesday. VIDEO: Wednesday Sector Leaders: Shipping, Agriculture & Farm Products The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image source: The Motley Fool. Thursday, November 7, 2024 at 10:00 a.m. ET Call participants President and Chief Executive Officer — Barb Jacobsmeyer Chief Financial Officer — Crissy Carlisle Vice President of Finance — Jobie Williams Takeaways Consolidated net revenue -- $253.6 million, reflecting a 1.8% decrease year over year. -- $253.6 million, reflecting a 1.8% decrease year over year. Consol...
Image source: The Motley Fool. Thursday, November 7, 2024 at 10:00 a.m. ET Call participants President and Chief Executive Officer — Barb Jacobsmeyer Chief Financial Officer — Crissy Carlisle Vice President of Finance — Jobie Williams Takeaways Consolidated net revenue -- $253.6 million, reflecting a 1.8% decrease year over year. -- $253.6 million, reflecting a 1.8% decrease year over year. Consolidated adjusted EBITDA -- $24.5 million, a 5.6% increase year over year. -- $24.5 million, a 5.6% increase year over year. Home health segment revenue -- Decreased $9.9 million, or 4.7% year over year, attributed to declining recertifications. -- Decreased $9.9 million, or 4.7% year over year, attributed to declining recertifications. Non-Medicare home health admissions -- Increased 20.1%, driving total admissions growth of 5.6% year over year, with same-store admissions up 5.5%. -- Increased 20.1%, driving total admissions growth of 5.6% year over year, with same-store admissions up 5.5%. Payor innovation contracts -- 45% of non-Medicare home health visits now covered, up from 19% a year ago; 73% of total home health admissions combined in Medicare fee-for-service and payor innovation contracts. -- 45% of non-Medicare home health visits now covered, up from 19% a year ago; 73% of total home health admissions combined in Medicare fee-for-service and payor innovation contracts. Medicare fee-for-service home health admissions -- Declined 2.5% sequentially from fiscal Q2 (period ended June 30, 2024), an improvement versus a 4.7% sequential decline the prior year; 44% share of total home health admissions unchanged over the last three quarters. -- Declined 2.5% sequentially from fiscal Q2 (period ended June 30, 2024), an improvement versus a 4.7% sequential decline the prior year; 44% share of total home health admissions unchanged over the last three quarters. Home health adjusted EBITDA -- Decreased $5.3 million, or 12.7% year over year, due to revenue contraction. -- Decreas...
Williams-Sonoma announced today that its Board of Directors has authorized a 15% increase in the company's quarterly cash dividend to $0.76 per common share. The quarterly dividend is payable on May 22, 2026, to stockholders of record as of the close of business on April 17, 2026. On March 17, 2026, the Board of Directors of Waterstone Financial, declared a regular quarterly cash dividend of $0.17...
Williams-Sonoma announced today that its Board of Directors has authorized a 15% increase in the company's quarterly cash dividend to $0.76 per common share. The quarterly dividend is payable on May 22, 2026, to stockholders of record as of the close of business on April 17, 2026. On March 17, 2026, the Board of Directors of Waterstone Financial, declared a regular quarterly cash dividend of $0.17 per common share, a 13.3% increase compared to the prior quarterly dividend. "Today's announcement of a dividend increase underscores our disciplined execution of the Company's business strategy and reflects our confidence in Waterstone Financial's future," said William Bruss, Chief Executive Officer of Waterstone Financial, Inc. "Maintaining a robust dividend payout ratio remains a priority for us, affirming our commitment to delivering long-term value to our shareholders and effective management of our capital." The dividend increase is effective with the dividend payable on May 1, 2026, to shareholders of record at the close of business on April 8, 2026. Fulton Financial today announced that its Board of Directors declared a quarterly cash dividend of nineteen cents per share on its common stock, payable on April 15, 2026, to shareholders of record as of April 1, 2026. Mid-America Apartment Communities, today announced that its board of directors approved a quarterly dividend payment of $1.53 per share of common stock to be paid on April 30, 2026, to shareholders of record on April 15, 2026. This announcement represents the 129th consecutive quarterly cash dividend declared by the company. MAA has never reduced or suspended its quarterly common dividend payment in its over 30-year history as a public company. As established in prior quarters, the board of directors declared the quarterly common dividend in advance of MAA's earnings announcement that is expected to be made on April 29, 2026. The board of directors of NiSource today declared a quarterly common stock divid...
At Etsy, Zoë Weil helped to drive a billion-dollar increase in gross merchandise volume within a single year by improving the online marketplace’s AI ranking systems. With her new startup, Sequen, she aims to bring her and her co-founders’ years of AI research and product development to other businesses in the consumer space. The company, which just closed on $16 million in Series A funding, offer...
At Etsy, Zoë Weil helped to drive a billion-dollar increase in gross merchandise volume within a single year by improving the online marketplace’s AI ranking systems. With her new startup, Sequen, she aims to bring her and her co-founders’ years of AI research and product development to other businesses in the consumer space. The company, which just closed on $16 million in Series A funding, offers real-time personalization technology and ranking infrastructure — technology used by the world’s biggest tech firms, but which has been inaccessible to other large consumer businesses because of the massive datasets required. While those outside the tech industry may not understand what this technology involves, anyone who’s used consumer apps like TikTok, Instagram, or YouTube has been the target of these systems. Explains Weil, Sequen CEO, “modern tech isn’t really recommending content anymore. It’s bending your will in subtle ways over time to make you actually want things. And, in fact, the tech has gotten so good that a lot of people suspect platforms are eavesdropping on their conversations,” she says. Weil credits this phenomenon to something called the Large Event Model. While Large Language Models (LLMs) used by chatbots like ChatGPT generalize text, Large Event Models generalize streams of events and human behavior in particular. This technology has use cases that go beyond building a better algorithm. Image Credits:Sequen Weil believes that Sequen could eventually replace the cookie — a tracking technology that personalizes web experiences for end users, but in a way that has raised privacy concerns and triggered regulation. “Our large event models learn from live user actions, not just clicks and scrolls, but also hovers, conversations and stuff within a given session — not static profiles or third-party cookies,” Weil says. “That’s how you personalize in real-time, even with sparse data. So yes, we do unlock TikTok’s algorithms for Fortune 500 companies that ...
The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.34%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.21%. March E-mini S&P futures (ESH26) are down -0.30%, and March E-mini Nasdaq futures (NQH26) are down -0.27%. Stocks gave up overnight gains and turned lower today after US Feb producer prices rose more than expected, a sign of stic...
The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.34%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.21%. March E-mini S&P futures (ESH26) are down -0.30%, and March E-mini Nasdaq futures (NQH26) are down -0.27%. Stocks gave up overnight gains and turned lower today after US Feb producer prices rose more than expected, a sign of sticky price pressures. Also, WTI crude oil prices (CLJ26) whipsawed higher by more than +2% after initially being down more than -2% on signs of escalation of the Iran war after Iran said part of its South Pars gas field was hit in an airstrike, as were the Asaluyeh oil industry facilities. Join 200K+ Subscribers: Stock index futures initially moved higher today after crude oil prices fell more than -2% when Iraq said it will resume crude exports through a pipeline that links Kurdistan to Turkey’s Mediterranean port of Ceyhan, bypassing the Strait of Hormuz. Also, the US dropped 5,000-pound bunker-buster bombs on Iranian missile sites near the Strait of Hormuz. The war against Iran entered its nineteenth day today with no signs of easing as Iran stepped up attacks on its Middle Eastern neighbors in retaliation for the killing of its security chief, Ali Larijani, in an Israeli strike. Iran today launched fresh waves of missiles and drone attacks, targeting the United Arab Emirates, Saudi Arabia, Kuwait, and Israel. Crude oil prices remain high despite attempts to boost global supplies. The IEA last Wednesday released 400 million barrels from emergency oil stockpiles and said the war against Iran is disrupting 7.5% of global oil supply, and the conflict will cut global oil supply by 8 million bpd this month. The closure of the Strait of Hormuz, through which about a fifth of the world’s oil and natural gas flows, has choked off oil and gas flows due to Iran’s attacks on shipping in the waterway and forced Gulf producers to cut output because they can’t export from the region. Ir...
Image source: The Motley Fool. Thursday, March 6, 2025 at 9 a.m. ET Call participants President — David deVilliers III Chief Executive Officer — John Baker III Chief Financial Officer — Matthew McNulty Need a quote from a Motley Fool analyst? Email [email protected] Risks CEO Baker stated, "we expect NOI in 2025 to remain flat if not slightly below 2024," citing non-repeatable one-time Mining Roya...
Image source: The Motley Fool. Thursday, March 6, 2025 at 9 a.m. ET Call participants President — David deVilliers III Chief Executive Officer — John Baker III Chief Financial Officer — Matthew McNulty Need a quote from a Motley Fool analyst? Email [email protected] Risks CEO Baker stated, "we expect NOI in 2025 to remain flat if not slightly below 2024," citing non-repeatable one-time Mining Royalty segment gains, and negative near-term impact from Industrial/Commercial vacancies. Significant Cranberry Business Park occupancy declines are expected, as management disclosed, "feet defaulted on us, they’re not coming back. That in and of itself will take Cranberry from 96% occupancy to 60% occupancy." President deVilliers III indicated earnings drag from new project deliveries before lease-up, stating, "This will impact NOI negatively until it is occupied and stabilized, where after the operating expenses can be passed through to tenants and receive rent revenue." Construction cost uncertainty linked to tariffs was noted, with management observing that, "Construction costs are entering a period of uncertainty as we await the impact of tariffs on steel, lumber, and gypsum." Takeaways Quarterly net income -- $1.68 million, down 41.7% from $2.88 million, which previously included a one-time $1.98 million gain from a loan guarantee termination at Bryant Street Project. -- $1.68 million, down 41.7% from $2.88 million, which previously included a one-time $1.98 million gain from a loan guarantee termination at Bryant Street Project. Annual net income -- $6.39 million, up 20.4% from $5.3 million, primarily driven by improved Multifamily results. -- $6.39 million, up 20.4% from $5.3 million, primarily driven by improved Multifamily results. Pro rata NOI (quarter) -- $9.1 million, up 21%, with Multifamily projects delivering an added $4.6 million over last year. -- $9.1 million, up 21%, with Multifamily projects delivering an added $4.6 million over last year. Pro rata NOI (ye...
Goldman Sachs Group Inc. bankers say companies can’t afford to wait out the latest wave of volatility gripping markets to pursue strategic mergers and acquisitions. “If you wait for perfection, you may struggle to get your deal done,” Nimesh Khiroya , the Wall Street bank’s co-head of M&A for Europe, the Middle East and Africa, said in an interview. “You’ve got to balance strategic impetus with ma...
Goldman Sachs Group Inc. bankers say companies can’t afford to wait out the latest wave of volatility gripping markets to pursue strategic mergers and acquisitions. “If you wait for perfection, you may struggle to get your deal done,” Nimesh Khiroya , the Wall Street bank’s co-head of M&A for Europe, the Middle East and Africa, said in an interview. “You’ve got to balance strategic impetus with managing volatility.” Goldman Sachs is forecasting pure M&A volumes of $3.8 trillion for 2026 — a slight increase on last year’s haul. That’s despite a challenging start to the year that’s already brought a technology selloff, private credit writedowns and surging energy prices due to the war in Iran. Speaking on the sidelines of a Goldman Sachs and McKinsey & Co. European M&A conference in London this week, Khiroya said markets had grown accustomed to uncertainty since the Covid pandemic and that investment bankers at his firm see transactions continuing. Data compiled by Bloomberg show that global M&A values are down roughly 3% year-on-year at about $605 billion. A week ago, they’d still been trending higher. Deal numbers are also falling, with some advisers warning timetables could get stretched the longer the conflict in the Middle East goes on. ‘Don’t Wait’ The decision by Israel and the US to launch military strikes on Iran in late February has injected significant uncertainty into the global business outlook, with the ongoing war creating fresh inflationary pressures that threaten economic growth. This has forced Wall Street to reassess predictions of interest rate cuts by the Federal Reserve this year, which many thought could help drive M&A activity to new highs. Goldman Sachs has pushed back its rate cut estimations, citing rising energy prices. In comments that echoed Khiroya, Tim Ingrassia , Goldman Sachs’ co-chairman of global M&A, said companies shouldn’t let potential delays to rate cuts stifle plans for acquisitions. “The stability of long term interest rates ...
Macy’s (NYSE:M) stock is up 5% in Wednesday morning trading, with shares climbing toward $18 after the company posted a stronger-than-expected fourth quarter of FY2025. The move stands out given that the broader consumer cyclical sector is down 0.83% today and the S&P 500 has slipped 0.48%, making Macy’s one of the few retail names ... Macy’s Rises 5%: The Department Store Fighting Back in Amazon’...
Macy’s (NYSE:M) stock is up 5% in Wednesday morning trading, with shares climbing toward $18 after the company posted a stronger-than-expected fourth quarter of FY2025. The move stands out given that the broader consumer cyclical sector is down 0.83% today and the S&P 500 has slipped 0.48%, making Macy’s one of the few retail names ... Macy’s Rises 5%: The Department Store Fighting Back in Amazon’s World
Key Points Superstring Capital Management purchased 37,433 shares of Axsome Therapeutics in the fourth quarter. The quarter-end position value was $6.84 million, representing a new holding in Axsome Therapeutics. The position accounts for 3.66% of Superstring Capital Management LP’s 13F assets under management as of December 31. 10 stocks we like better than Axsome Therapeutics › On February 17, 2...
Key Points Superstring Capital Management purchased 37,433 shares of Axsome Therapeutics in the fourth quarter. The quarter-end position value was $6.84 million, representing a new holding in Axsome Therapeutics. The position accounts for 3.66% of Superstring Capital Management LP’s 13F assets under management as of December 31. 10 stocks we like better than Axsome Therapeutics › On February 17, 2026, Superstring Capital Management disclosed a new position in Axsome Therapeutics (NASDAQ:AXSM), acquiring 37,433 shares worth $6.84 million in the fourth quarter. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Superstring Capital Management initiated a new position in Axsome Therapeutics during the fourth quarter of 2025. The fund bought 37,433 shares worth $6.84 million at quarter’s end. What else to know This new position represents nearly 4% of Superstring Capital Management LP’s 13F assets under management at quarter’s end. Top holdings after the filing: NASDAQ: CDTX: $18.80 million (10.1% of AUM) NASDAQ: TERN: $17.93 million (9.6% of AUM) NASDAQ: URGN: $16.82 million (9.0% of AUM) NASDAQ: COGT: $13.01 million (7.0% of AUM) NASDAQ: DVAX: $8.08 million (4.3% of AUM) As of Wednesday, shares of Axsome Therapeutics were priced at $158.40, up 27% over the past year and well outperforming the S&P 500’s roughly 19% gain in the same period. Company overview Metric Value Revenue (TTM) $638.5 million Net Income (TTM) ($183.2 million) Market Capitalization $8.1 billion Price (as of Wednesday) $158.40 Company snapshot Axsome Therapeutics develops and commercializes novel therapies targeting central nervous system (CNS) disorders, with a pipeline including AXS-05 for major depressive disorder and Alzheimer’s disease agitation, AXS-07 for migraine, AXS-12 for narcolepsy, and AXS-14 for fibromyalgia. The company’s business model centers on proprietary drug development, advancing candidates through clinical trials and regulatory...